Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.

[1]  H. Lehr,et al.  Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis. , 2006, Radiology.

[2]  E. Hauth,et al.  Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography. , 2006, Clinical imaging.

[3]  L. Liberman,et al.  Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. , 2006, AJR. American journal of roentgenology.

[4]  Antoine Rosset,et al.  Informatics in radiology (infoRAD): navigating the fifth dimension: innovative interface for multidimensional multimodality image navigation. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[5]  Benjamin M Yeh,et al.  Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Edna Schechtman,et al.  Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions , 2005, Cancer.

[7]  S. Obenauer,et al.  [Retrospective analysis of a computer-aided detection (CAD) system in full-field digital mammography in correlation to tumor histology]. , 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[8]  O. Rieker,et al.  Selbstorganisierende neuronale Netze zur automatischen Detektion und Klassifikation von Kontrast(mittel)-verstärkten Läsionen in der dynamischen MR-Mammographie , 2005 .

[9]  Peter Aspelin,et al.  Application of artificial neural networks to the analysis of dynamic MR imaging features of the breast , 2004, European Radiology.

[10]  Weijing Sun,et al.  Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Frederick Kelcz,et al.  Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. , 2002, AJR. American journal of roentgenology.

[12]  M. Schmidt,et al.  Eine Kombination niedrig und hochauflösender dynamischer T1-gewichteter Sequenzen zur besseren Beurteilung der Morphologie Kontrastmittel aufnehmender Läsionen in der MRT der weiblichen Brust , 2002 .

[13]  Edna Furman-Haran,et al.  Parametric analysis of breast MRI. , 2002, Journal of computer assisted tomography.

[14]  F. Kelcz,et al.  Critical role of spatial resolution in dynamic contrast‐enhanced breast MRI , 2001, Journal of magnetic resonance imaging : JMRI.

[15]  D. Ikeda,et al.  Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. , 2001, Radiology.

[16]  R. Hendrick,et al.  Correlation of high‐resolution breast MR imaging with histopathology; validation of a technique , 2000, Journal of magnetic resonance imaging : JMRI.

[17]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[18]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[19]  S G Orel,et al.  Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor? , 1999, Radiology.

[20]  J. Gomori,et al.  Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging--pilot study. , 1999, Radiology.

[21]  H. Degani,et al.  Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  H. Degani,et al.  Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. , 1997, Journal of magnetic resonance.

[23]  Scott Fields,et al.  Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.

[24]  A Horsman,et al.  Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis methods. , 1997, Journal of computer assisted tomography.

[25]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[26]  Torsten Sommer,et al.  Standardisierung und Beschleunigung der quantitativen Analyse dynamischer MR-Mammographien durch Parameterbilder und automatisierte ROI-Definition , 1996 .

[27]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[28]  L J van Erning,et al.  MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.

[29]  O Lucidarme,et al.  Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. , 1994, Radiology.

[30]  M D Schnall,et al.  Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. , 1994, Radiology.

[31]  P. Tofts,et al.  Ni-DTPA doped agarose gel--a phantom material for Gd-DTPA enhancement measurements. , 1993, Magnetic resonance imaging.

[32]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[33]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.